In summary, tissue-specific CDH17 works as a regulator of CRC SC biology by modulating LGR5 expression, Wnt signaling, MYC expression, and, therefore, stemness, and drug resistance capacities through SLC38A5 in metastatic cells (Fig. 8). Here, SLC38A5 is linked to colorectal carcinoma.